A detailed history of Verition Fund Management LLC transactions in Kura Oncology, Inc. stock. As of the latest transaction made, Verition Fund Management LLC holds 88,395 shares of KURA stock, worth $796,438. This represents 0.01% of its overall portfolio holdings.

Number of Shares
88,395
Previous 190,009 53.48%
Holding current value
$796,438
Previous $3.91 Million 55.85%
% of portfolio
0.01%
Previous 0.02%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$18.57 - $23.23 $1.89 Million - $2.36 Million
-101,614 Reduced 53.48%
88,395 $1.73 Million
Q2 2024

Aug 14, 2024

SELL
$17.53 - $22.98 $3.01 Million - $3.95 Million
-171,811 Reduced 47.49%
190,009 $3.91 Million
Q1 2024

May 14, 2024

SELL
$13.42 - $23.53 $1.39 Million - $2.44 Million
-103,773 Reduced 22.29%
361,820 $7.72 Million
Q4 2023

Feb 14, 2024

BUY
$7.58 - $14.38 $3.53 Million - $6.7 Million
465,593 New
465,593 $6.7 Million
Q3 2022

Nov 14, 2022

BUY
$12.01 - $19.45 $458,217 - $742,075
38,153 Added 7.09%
576,240 $7.87 Million
Q2 2022

Aug 15, 2022

BUY
$10.71 - $18.33 $481,403 - $823,915
44,949 Added 9.11%
538,087 $9.86 Million
Q1 2022

May 13, 2022

BUY
$11.78 - $16.98 $5.81 Million - $8.37 Million
493,138 New
493,138 $7.93 Million
Q4 2021

Feb 14, 2022

SELL
$12.22 - $19.57 $950,092 - $1.52 Million
-77,749 Closed
0 $0
Q3 2021

Nov 15, 2021

SELL
$15.42 - $21.72 $3.12 Million - $4.39 Million
-202,337 Reduced 72.24%
77,749 $1.46 Million
Q2 2021

Aug 16, 2021

BUY
$20.85 - $29.88 $1.77 Million - $2.54 Million
85,001 Added 43.57%
280,086 $5.84 Million
Q1 2021

May 18, 2021

BUY
$24.75 - $39.14 $1.28 Million - $2.03 Million
51,788 Added 36.14%
195,085 $5.52 Million
Q4 2020

Feb 16, 2021

BUY
$29.0 - $41.62 $2.49 Million - $3.57 Million
85,776 Added 149.12%
143,297 $4.68 Million
Q3 2020

Nov 16, 2020

BUY
$16.3 - $30.64 $937,592 - $1.76 Million
57,521 New
57,521 $1.76 Million

Others Institutions Holding KURA

About Kura Oncology, Inc.


  • Ticker KURA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 66,893,000
  • Market Cap $603M
  • Description
  • Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...
More about KURA
Track This Portfolio

Track Verition Fund Management LLC Portfolio

Follow Verition Fund Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Verition Fund Management LLC with notifications on news.